Moderna, Inc.
MRNA
Revenue
241.00M
▲74.00M▲44.31%
3 Months ChangeAssets
15.68B
▼-1.05B▼-6.27%
3 Months ChangeLiabilities
3.97B
▲56.00M▲1.43%
3 Months ChangeFree Cash Flow
-1.19B
▲153.00M▲11.43%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-02
Form 8-K
ID: 0001682852-24-000052
2024-09-12
Form 8-K
ID: 0001682852-24-000049
2024-08-01
Form 10-Q
ID: 0001682852-24-000046
2024-08-01
Form 8-K
ID: 0001682852-24-000043
2024-07-23
Form 8-K
ID: 0001682852-24-000035
2024-05-09
Form 8-K
ID: 0001682852-24-000031
2024-05-02
Form 10-Q
ID: 0001682852-24-000027
2024-05-02
Form 8-K
ID: 0001682852-24-000023
2024-02-22
Form 8-K
ID: 0001682852-24-000010
2024-01-08
Form 8-K
ID: 0001682852-24-000004